Chemical Cos. Settle Spat Over Cystic Fibrosis Drug

Law360, New York (July 11, 2006, 12:00 AM EDT) -- Chemical company Solvay Pharmaceuticals Inc. has resolved a lawsuit against Global Pharmaceuticals and Impax Laboratories Inc., claiming that the companies falsely advertised their products as generic versions of a brand-name drug used to treat patients with cystic fibrosis.

As part of the settlement announced Tuesday, Global and Impax will pay $23 million to Solvay and will stop their marketing practices dating back to 1998 that imply that its products are generic equivalents to Creon, the brand-name product.

Impax and Global, which markets the generic products made...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.